EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeit

Ergothioneine as a potential geroprotector: Targeting molecular hallmarks of ageing and age-related diseases

Pengfei Zhao, Ying Qi

Ageing Research Reviews · 2026

DOI: 10.1016/j.arr.2026.103158 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Ageing Research Reviews, 2026. Verfasst von Pengfei Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China. Hauptthemen laut MEDLINE: Ergothioneine, Aging, Antioxidants. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 194 Literaturangaben. Gefördert von: Scientific Research Fund of Liaoning Provincial Education Department, China Medical University, Shengjing Hospital of China Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypothesized to be a diet-derived 'longevity vitamin', Ergothioneine (ET) is increasingly recognized for its potential to modulate cellular homeostasis and support healthy ageing in preclinical models. This systematic review, encompassing evidence from 2005 to 2025, investigates ET's unique pharmacokinetics mediated by the OCTN1 (SLC22A4) transporter, which ensures its selective accumulation in tissues susceptible to age-related oxidative decline. Beyond its role as a secondary antioxidant buffer, we critically evaluate ET's ability to target molecular hallmarks of ageing, specifically focusing on telomere maintenance, mitochondrial integrity, and the NRF2-mediated cytoprotective response. Utilizing network pharmacology, this review deciphers the multi-target regulatory landscape of ET in mitigating neurodegeneration, cardiovascular remodeling, and metabolic dysfunction. Furthermore, we address clinical gaps by discussing ET's potential utility as a candidate biomarker of biological aging and emphasizing the necessity of precision nutrition strategies incorporating SLC22A4/SLC22A15 genetic stratification. By synthesizing mechanistic insights and longitudinal human data, we highlight ET as an emerging candidate with geroprotective potential that warrants rigorous clinical evaluation for extending healthspan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErgothioneineAgingAntioxidantsHumansAnimalsOrganic Cation Transport ProteinsSymporters

Stichwörter der Autor:innen

Anti-inflammatoryAntioxidantErgothioneineMedicine food homologyTherapeutic potentialToxicology

Substanzen

ErgothioneineAntioxidantsOrganic Cation Transport ProteinsSLC22A4 protein, humanSymporters

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: womanman1982@163.com.

Förderung

  • Scientific Research Fund of Liaoning Provincial Education Department
  • China Medical University
  • Shengjing Hospital of China Medical University

Zitieren

APA

Zhao, P., & Qi, Y. (2026). Ergothioneine as a potential geroprotector: Targeting molecular hallmarks of ageing and age-related diseases. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2026.103158

Vancouver

Zhao P, Qi Y. Ergothioneine as a potential geroprotector: Targeting molecular hallmarks of ageing and age-related diseases. Ageing Research Reviews. 2026. doi:10.1016/j.arr.2026.103158

BibTeX
@article{Zhao2026,
  author = {Zhao, Pengfei and Qi, Ying},
  title = {Ergothioneine as a potential geroprotector: Targeting molecular hallmarks of ageing and age-related diseases},
  journal = {Ageing Research Reviews},
  year = {2026},
  doi = {10.1016/j.arr.2026.103158}
}
Kostenlos starten →